CbdMD Analyst Ratings
CbdMD Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/05/2023 | 210.24% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
06/18/2021 | 236.09% | Cantor Fitzgerald | $4.1 → $3.25 | Reinstates | → Neutral |
02/03/2021 | 323.99% | Cantor Fitzgerald | $4.3 → $4.1 | Reiterates | → Neutral |
01/29/2021 | 344.67% | Cantor Fitzgerald | $3.6 → $4.3 | Maintains | Neutral |
09/09/2020 | 313.65% | Benchmark | $3 → $4 | Maintains | Speculative Buy |
08/13/2020 | 272.29% | Cantor Fitzgerald | $1.8 → $3.6 | Maintains | Neutral |
05/18/2020 | 86.14% | Cantor Fitzgerald | $1.2 → $1.8 | Maintains | Neutral |
12/19/2019 | 623.89% | Benchmark | $9 → $7 | Maintains | Speculative Buy |
11/08/2019 | 251.6% | Cantor Fitzgerald | → $3.4 | Initiates Coverage On | → Neutral |
09/10/2019 | 830.71% | Benchmark | → $9 | Initiates Coverage On | → Speculative Buy |
日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
10/05/2023 | 210.24% | Maxim 集團 | → 3 美元 | 啓動覆蓋範圍開啓 | → 購買 |
06/18/2021 | 236.09% | 坎託·菲茨傑拉德 | 4.1 美元 → 3.25 美元 | 恢復 | → 中立 |
02/03/2021 | 323.99% | 坎託·菲茨傑拉德 | 4.3 美元 → 4.1 美元 | 重申 | → 中立 |
2021 年 1 月 29 日 | 344.67% | 坎託·菲茨傑拉德 | 3.6 美元 → 4.3 美元 | 維護 | 中立 |
2020 年 9 月 9 日 | 313.65% | 基準 | 3 美元 → 4 美元 | 維護 | 投機性買入 |
08/13/2020 | 272.29% | 坎託·菲茨傑拉德 | 1.8 美元 → 3.6 美元 | 維護 | 中立 |
2020 年 5 月 18 日 | 86.14% | 坎託·菲茨傑拉德 | 1.2 美元 → 1.8 美元 | 維護 | 中立 |
12/19/2019 | 623.89% | 基準 | 9 美元 → 7 美元 | 維護 | 投機性買入 |
11/08/2019 | 251.6% | 坎託·菲茨傑拉德 | → 3.4 美元 | 啓動覆蓋範圍開啓 | → 中立 |
09/10/2019 | 830.71% | 基準 | → 9 美元 | 啓動覆蓋範圍開啓 | → 投機性買入 |
What is the target price for cbdMD (YCBD)?
cbdMD(YCBD)的目標價格是多少?
The latest price target for cbdMD (AMEX: YCBD) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $3.00 expecting YCBD to rise to within 12 months (a possible 210.24% upside). 1 analyst firms have reported ratings in the last year.
Maxim集團於2023年10月5日公佈了cbdMD(美國證券交易所股票代碼:YCBD)的最新目標股價。該分析公司將目標股價定爲3.00美元,預計YCBD將在12個月內升至12個月內(可能上漲210.24%)。1家分析公司去年公佈了評級。
What is the most recent analyst rating for cbdMD (YCBD)?
cbdMD(YCBD)的最新分析師評級是多少?
The latest analyst rating for cbdMD (AMEX: YCBD) was provided by Maxim Group, and cbdMD initiated their buy rating.
CbdMD(美國證券交易所股票代碼:YCBD)的最新分析師評級由Maxim集團提供,CbdMD啓動了買入評級。
When is the next analyst rating going to be posted or updated for cbdMD (YCBD)?
CbdMD(YCBD)的下一次分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of cbdMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for cbdMD was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與cbdMD的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。cbdMD的最後一次評級是在2023年10月5日提交的,因此您應該預計下一個評級將在2024年10月5日左右公佈。
Is the Analyst Rating cbdMD (YCBD) correct?
分析師評級 cbdMD (YCBD) 是否正確?
While ratings are subjective and will change, the latest cbdMD (YCBD) rating was a initiated with a price target of $0.00 to $3.00. The current price cbdMD (YCBD) is trading at is $0.97, which is within the analyst's predicted range.
儘管評級是主觀的,並將發生變化,但最新的cbdMD(YCBD)評級是啓動的,目標股價爲0.00美元至3.00美元。cbdMD(YCBD)目前的交易價格爲0.97美元,在分析師的預測區間內。
譯文內容由第三人軟體翻譯。